DongZhu Xu Selected Research

DongZhu Xu Research Topics

4	Atrial Fibrillation 12/2022 - 06/2020
3	Hypertension (High Blood Pressure) 02/2023 - 08/2014
3	Myocardial Infarction 02/2023 - 01/2019
3	Fibrosis (Cirrhosis) 12/2022 - 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2023
1	Stroke (Strokes) 02/2023
1	Pneumonia (Pneumonitis) 02/2023
1	Neoplasms (Cancer) 02/2023
1	Atrial Remodeling 12/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Myocarditis (Carditis) 01/2021
1	Obesity 06/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Inflammation (Inflammations) 01/2017

3	CalciumIBA 10/2021 - 01/2019
2	3-methylquercetinIBA 12/2022 - 01/2020
2	NAD (NADH)IBA 10/2021 - 06/2020
2	Nicotinamide PhosphoribosyltransferaseIBA 10/2021 - 06/2020
1	CollagenIBA 01/2022
1	Nonsense Codon (Nonsense Mutation)IBA 01/2022
1	Xanthine OxidaseIBA 10/2021
1	Allopurinol (Remid)FDA LinkGeneric 10/2021
1	Febuxostat FDA Link 10/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2021
1	B7-H1 AntigenIBA 01/2021
1	LigandsIBA 01/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	SR9009IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 08/2014

1	Length of Stay 02/2023
1	Blood Transfusion (Blood Transfusions) 02/2023
1	Denervation 08/2014